Primary hyperparathyroidism: Epidemiology and clinical consequences

Clinical Reviews in Bone and Mineral Metabolism

Volumn 1, Issue 1, 2002, Pages 25-34

  Bilezikian, John P ^a   Silverberg, Shonni J ^a  

^a Columbia University New York ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

AMINO ACID ANALYSIS; AUTOANALYZER; AUTOPSY; BIOLOGICAL MONITORING; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CARDIOVASCULAR SYSTEM; CHEMICAL ANALYSIS; CLINICAL FEATURE; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; HYPERCALCEMIA; IMAGE ANALYSIS; INCIDENCE; MORTALITY; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POPULATION RESEARCH; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME;

EID: 0041386242     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:1:1:25     Document Type: Review

References (85)

1. Heath H III, Hodgson SF, Kennedy M. 1980 Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 302:189-193.
2. Cope O. 1966 The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 21(1):174-182.
3. Keating FR Jr, Cook EN. 1945 Recognition of primary hyperparathyroidism: analysis of 24 cases. J Am Med Assoc 129:994-1002.
4. Melton LJ III. 1991 Epidemiology of primary hyperparathyroidism. J Bone Miner Res 6(Suppl 2):S25-S30.
5. Stenstrom G, Heedman P. 1974 Clinical findings in patients with hypercalcemia: a final investigation based on biochemical screening. Acta Med Scand 195:473-477.
6. Rastad J, Lundgren E, Ljunghall S. 2001 Clinical presentation of primary hyperparathyroidism. In: The Parathyroids, 2nd ed. Bilezikian JP. Marcus R, Levine MA, eds. Academic, San Diego, CA, 361-374.
7. Palmer M, Jacobsson G, Akerstrom G, Ljunghall S. 1988 Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 18:39-46.
8. Christensson T, Hellstrom K, Wengle B, Alveryd A, Wikland B. 1976 Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 200:131-137.
9. Akerstrom G, Rudberg C, Grimelius L, Bergstrom R, Johansson H, Ljunghall S, et al. 1986 Histologic parathyroid abnormalities in an autopsy series. Hum Pathol 17:520-527.
10. Lundgren E, Rastad J, Thurfjell E, Akerstrom G, Ljunghall S. 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121:287-294.
11. Lundgren E. 1999 Primary hyperparathyroidism of postmenopausal females. Prospective case-control analysis on prevalence, clinical characteristics and treatment. Comprehensive Summary Uppsula Faculty Medicine 820:1-51.
12. Lindstedt G, Nystrom E, Lundberg P-A, Johansson E, Eggertsen R. 1992 Screening of an elderly population in primary care for primary hyperparathyroidism. Scand J Primary Health Care 10:192-197.
13. Sorva A, Valvanne J, Tilvis RS. 1992 Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med 231:309-312.
14. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. 1997 The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 126:433-440.
15. Cohen J, Gierlowski TC, Schneider AB. 1990 A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA 264:581-584.
16. Bondeson AG, Bondeson L, Thompson NW. 1989 Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence? Surgery 106:1025-1027.
17. Gao P, Scheibel S, D' Amour P, John MR, Rao SD, Schmidt-Gayk H, et al. 2001. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84 implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614.
18. Silverberg SJ, Brown IN, Bilezikian JP, Deftos LJ. 2000A new highly sensitive assay for parathyroid hormone in primary hyperparathyroidism. J Bone Miner Res 15(Suppl I):S167.
19. Cohen A, LoGerfo P, Gao P, Brown IB, Trokan S, Cantor T, et al. 2001 PTH(1-84) and N-truncated PTH fragment in the serum and parathyroid glands of patients with primary hyperparathyroidism. J Bone Miner Res 16(Suppl I):S156.
20. Silverberg SJ, Bilezikian JP. 2001 Primary hyperparathyroidism. In: Principles and Practice of Endocrinology and Metabolism. Becker KL, ed. Lippincott Willliams & Wilkins, Philadelphia, 564-573.
21. Bilezikian JP. 1996 Nephrolithiasis in primary hyperparathyroidism. In: Kidney Stones: Medical and Surgical Treatment. Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, eds. Lippincott-Raven Philadelphia, 783-802.
22. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. 1991 Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Miner Res 6(Suppl I):585-589.
23. Silverberg SJ, Shane E, DeLaCruz L, et al. 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283-291.
24. Bilezikian JP, Silverberg SJ. 2000 Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 1:237-245.
25. Silverberg SJ, Bilezikian JP. 2001 Primary hyperparathyroidism. In: Endocrinology, 4th ed. DeGroot LJ, Jameson JL, eds. WB Saunders, Philadelphia, 1075-1093.
26. Dauphine RT, Riggs BL, Scholz DA. 1975 Back pain and vertebral crush fractures: an unrecognized mode of presentation for primary hyperparathyroidism. Ann Intern Med 83:365-367.
27. Khosla S, Melton III LJ, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. 1999 Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Min Res 14:1700-1707.
28. Wilson RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM. 1988 Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109:959-962.
29. Melton III LJ, Atkinson EJ, O'Fallon WM, Heath III H. 1992 Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152:2269-2273.
30. Kleerekoper M, Peterson E, Nelson D, et al. 1989 Identification of women at risk for developing post-menopausal osteoporosis with vertebral compression fractures: role of history and single photon absorptiometry. Bone Miner 7:171-186.
31. Johnson BE, Lucasey B, Robinson RG, Lukert BP. 1989 Contributing diagnoses in osteoporosis. Arch Intern Med 149:1069-1072.
32. Ljunghall S, Palmer M, Akerstrom G, Wide L. 1983 Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest 13:373-377.
33. Bannon MP, vanHeerden JA, Palumbo PJ, Ilstrup DM. 1988 The relationship between primary hyperparathyroidism and diabetes mellitus. Ann Surg 207:430-433.
34. Silverberg SJ, Bilezikian JP. 2001 Clinical course of primary hyperparathyroidism. In: The Parathyroids, 2nd ed. Bilezikian JP, Marcus R, Levine MA, eds, Academic, San Diego. CA, 387-398.
35. Linos DA, vanHeerden JA, Abboud CF, Edis AJ. 1978 Primary hyperparathyroidism and peptic ulcer disease. Arch Surg 113:384-386.
36. Watson RG, vanHeerden JA, Grant CS, Klee GG. 1984 Postoperative hyperamylasemia, pancreatitis, and primary hyperparathyroidism. Surgery 96:1151-1157.
37. Sitges-Serra A, Alonso M, deLecea C, Gores PF, Sutherland DE. 1988 Pancreatitis and hyperparathyroidism. Br J Surg 75:158-160.
38. Prinz RA, Aranha GV. 1985 The association of primary hyperparathyroidism and pancreatitis. Am Surg 51:325-329.
39. vanLanschot JJ, Bruining HA. 1984 Primary hyperparathyroidism and pancreatitis. Netherlands J Surg 36:38-41.
40. Paloyan D, Simonowitz D, Paloyan E, Snyder TJ. 1982 Pancreatitis associated with primary hyperparathyroidism. Am Surg 48:366-368.
41. Bess MA, Edis AJ, van Heerden JA. 1980 Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243:246-247.
42. Turken SA, Cafferty M, Silverberg SJ, et al. 1989 Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87:553-557.
43. Joborn C, Rastad J, Stalberg E, Akerstrom G, Ljunghall S. 1989 Muscle function in patients with primary hyperparathyroidism. Muscle Nerve 12:87-94.
44. Wajngot A, Werner S, Granberg PO, Lindvall N. 1980 Occurrence of pituitary adenomas and other neoplastic diseases in primary hyperparathyroidism. Surg Gynecol Obstet 151:401-403.
45. Farr HW, Fahey TJ Jr, Nash AG, Farr CM. 1973 Primary hyperparathyroidism and cancer. Am J Surg 126:539-543.
46. Attie JN, Vardhan R. 1993 Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases. Head Neck 15:20-23.
47. Kambouris AA, Ansari MR, Talpos GT. 1987 Primary hyperparathyroidism and associated neoplasms. Henry Ford Med J 35:207-210.
48. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon M, et al. 1998 Survival after the diagnosis of hyperparathyroidism. Am J Med 104:115-122.
49. Palmer M, Adami H-O, Bergstrom R, Akerstroom G, Ljunghall S. 1987 Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102:1-7.
50. Hedback G, Tisell L-E, Bengtsson B-A, Hedman I, Oden A. 1990 Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14:829-836.
51. Palmer M, Adami H-O, Bergstrom R, Jakobsson S, Akerstrom G, Ljunghall S. 1987 Survival and renal function in persons with untreated hypercalcemia: a population-based cohort study with 14 years of follow-up. Lancet 1:59-62.
52. Hedback G, Oden A. 1998 Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest 28:271-276.
53. Hedback G, Oden A. 1998 Death risk factor analysis in primary hyperparathyroidism. Eur J Clin Invest 28:1011-1018.
54. Ronni-Sivula H, Sivula A. 1985 Long-term effect of surgical treatment on the symptoms of primary hyperparathyroidism. Ann Clin Res 17:141-147.
55. Walgenbach S, Hommel G, Junginger T. 2000 Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 24:564-569.
56. Hedback G, Oden A. 1991 The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 15:399-407.
57. Hedback G, Oden A, Tisell L-E. 1995 Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 117:134-139.
58. Hedback G, Oden A. 1999 Survival of patients operated on for primary hyperparathyroidism (letter). Surgery 125:240-241.
59. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. 2000 Primary hyperparathyroidism in women: New York and Beijing (A Tale of Two Cities). Int J Fertil Women's Health 45:158-165.
60. Mithal A, Bandeira F, Meng X, Silverberg S, Shi Y, Mishra SK, et al. 2001 Primary hyperparathyroidism in India, Brazil and China. In: The Parathyroids. 2nd ed. Bilezikian JP, Marcus R, Levine MA, eds. Academic, San Diego. CA, 375-386.
61. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. 1999 Vitamin D insufficiency in primary hyperparathyroidism. Am J Med 107:561-567.
62. Scholz DA, Purnell DC. 1981 Asymptomatic primary hyperparathyroidism. Mayo Clinic Proc 56:473-478.
63. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. 1999 The natural history of treated and untreated asymptomatic primary hyperparathyroidism: a ten year prospective study. N Engl J Med 341:1249-1255.
64. Parisien M, Dempster DW, Shane E, Bilezikian JP. 2001 Histomorphometric analysis of bone in primary hyperparathyroidism. In: The Parathyroids, 2nd ed. Bilezikian JP, Marcus R, Levine M, eds. Academic, San Diego. CA, 423-436.
65. Seibel MJ, Gartenberg F, Silverberg SJ, et al. 1942 Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 74:481-486.
66. Guo CY, Thomas WER, Al-Dehaimi AW, Assiri AMA, Eastell R. 1996 Longitudinal changes in bone mineral density and bone turnover in women with primary hyperparathyroidism. J Clin Endocrinol Metab 81:3487-3491.
67. Tanaka Y, Funahashi H, Imai T, Tominga Y, Takagi H. 1997 Parathyroid function and bone metabolic markers in primary and secondary hyperparathyroidism. Semin Surg Oncol 13:125-133.
68. Minisola S, Romagnoli E, Scarnecchia L, et al. 1994 Serum CITP in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 130:587-591.
69. Martin P, Bermann P, Sillet C. 1986 Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146:689-691.
70. Fuleihan GEH, Moore F Jr, LeBoff MS, Hurwitz S, Gundberg CM, Angell J, et al. 1999 Longitudinal changes in bone density in hyperparathyroidism. J Clin Densitom 2:153-162.
71. Silverberg SJ, Locker FG, Bilezikian JP. 1996 Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007-4012.
72. Deaconson TF, Wilson SD, Lemann J. 1987 The effect of parathyroidectomy on the recurrence of nephrolithiasis. Surgery 215:241-251.
73. Kaplan RA, Snyder WH, Stewart A, et al. 1976 Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 42:415-426.
74. Brown GG, Preisman RC, Kleerekoper MD. 1987 Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Med J 35:211-215.
75. Cogan MG, Covey CM, Arieff AI, Wisniewski A, Clark OH. 1978 Central nervous system manifestations of hyperparathyroidism. Am J Med 65:963-970.
76. Joborn C, Hetta J, Lind L, Rastad J, Akerstrom G, Ljunghall S. 1989 Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with longstanding mild hypercalcemia. Surgery 105:72-78.
77. Solomon BL, Schaaf M, Smallridge RC. 1994 Psychologic symptoms before and after parathyroid surgery. Am J Med 96:101-106.
78. Jones DB, Jones JH, Lloyd HJ, Lucas PA, Wilkins WE, Walker DA. 1983 Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad Med J 59:350-353.
79. Bradley EL III, Wells JO. 1983 Primary hyperparathyroidism and hypertension. Am Surg 49:569-570.
80. Rapado A. 1986 Arterial hypertension and primary hyperparathyroidism. Am J Nephrol 6(Suppl I):49-50.
81. Dominiczak AF, Lyall F, Morton JJ, et al. 1990 Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci 78:127-132.
82. Diamond TW, Botha JR, Wing J, Meyers AM, Kalk WJ. 1986 Parathyroid hypertension. A reversible disorder. Arch Intern Med 146:1709-1712.
83. Broulik PD, Horky K, Pacovsky V. 1985 Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy. Exp Clin Endocrinol 86:346-352.
84. Ringe JD. 1984 Reversible hypertension in primary hyperparathyroidism pre- and postoperative blood pressur in 75 cases. Kiln Wochenschr 62:465-469.
85. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B 1993 Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med, 95:197-202.